Prism Pharmaceuticals
Develops and commercializes branded cardiovascular injectable products
King of Prussia, PA
NYSE: BAX
Contact: Jim Currie
Formerly Known As: Prism Pharmaceuticals
Acquisition
Acquired by: Baxter International
Exit date: April 18, 2011
Case Study
Prism Pharmaceuticals is a specialty pharmaceutical company that engages in the development and commercialisation of acute care cardiovascular injectable products.
Essex Woodlands co-founded…
Learn More